EMD-14250

Single-particle
2.9 Å
EMD-14250 Deposition: 08/02/2022
Map released: 20/04/2022
Last modified: 23/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-14250

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7r40 summary report (pdf.gz) Map-7r40 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Structure of the SARS-CoV-2 spike glycoprotein in complex with the 87G7 antibody Fab fragment

EMD-14250

Single-particle
2.9 Å
EMD-14250 Deposition: 08/02/2022
Map released: 20/04/2022
Last modified: 23/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 spike glycoprotein in complex with the 87G7 antibody Fab fragment
Fitted models: 7r40

Deposition Authors: Hurdiss DL , Drulyte I
An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern.
PUBMED: 35471062
DOI: doi:10.1126/sciimmunol.abp9312
ISSN: 2470-9468